Leiomyosarcoma pathophysiology: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(9 intermediate revisions by the same user not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Leiomyosarcoma}}
{{Leiomyosarcoma}}
{{CMG}}{{AE}}{{Nnasiri}} {{Rekha}}
{{CMG}}{{AE}} {{Nnasiri}}
==Overview==
==Overview==
Leiomyosarcoma is a rare cancerous tumor that consists of smooth (involuntary) muscle cells. Leiomyosarcoma is an aggressive type of sarcoma. It spreads through the blood stream and can affect the lungs, liver, blood vessels, or any other soft tissue in the body. The exact cause of leiomyosarcoma is not known, although genetic and environmental factors appear to be involved.It is most often found in the uterus or abdomen.
Leiomyosarcoma is a rare cancerous tumor that consists of [[smooth muscle cells]]. It is an aggressive type of [[sarcoma]], spreads through the blood stream and can affect the [[lungs]], [[liver]], [[blood vessels]], or any other [[soft tissue]] in the body. The exact cause of leiomyosarcoma is not known, although [[genetic]] and [[environmental factor]]<nowiki/>s appear to be involved.It is most often found in the [[uterus]] or [[abdomen]].
 




==Pathophysiology==
==Pathophysiology==
The pathogenesis of [[leimyosarcoma]] is characterized by malignant smooth muscle neoplasm that can appear in any site in the body but most commonly found in the [[uterus,]][[small intestine]] and retro peritoneum.<ref name="pmid20430913">Arnold LM, Burman SD, O-Yurvati AH (2010) [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=20430913 Diagnosis and management of primary pulmonary leiomyosarcoma.] ''J Am Osteopath Assoc'' 110 (4):244-6. PMID: [https://pubmed.gov/20430913 20430913]</ref>
The [[pathogenesis]] of [[leimyosarcoma]] is characterized by malignant [[smooth muscle]] neoplasm that can appear in any site in the body but most commonly found in the uterus, [[small intestine]] and retro [[peritoneum]].<ref name="pmid20430913">Arnold LM, Burman SD, O-Yurvati AH (2010) [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=20430913 Diagnosis and management of primary pulmonary leiomyosarcoma.] ''J Am Osteopath Assoc'' 110 (4):244-6. PMID: [https://pubmed.gov/20430913 20430913]</ref>


=== Gross Pathology ===
=== Gross Pathology ===
On gross pathology, leiomyosarcoma appears to be soft, large, yellow or tan solitary masses with fleshy cut surfaces and areas of hemorrhage and necrosis.
On [[gross pathology]], leiomyosarcoma have the following characteristics:<ref name="WilkinsonRollason2001">{{cite journal|last1=Wilkinson|first1=N|last2=Rollason|first2=T P|title=Recent advances in the pathology of smooth muscle tumours of the uterus|journal=Histopathology|volume=39|issue=4|year=2001|pages=331–341|issn=0309-0167|doi=10.1046/j.1365-2559.2001.01300.x}}</ref>
* Large, solitary, poorly circumscribed masses with average size of 10 cm.
* Fleshy colorful cut surface with areas of [[hemorrhage]] or [[necrosis]].
 
=== Microscopic Pathology  ===
On microscopic pathological analysis, leimyosarvoma can have following characteristic, these are include: <ref name="pmid81790712">{{cite journal |vauthors=Bell SW, Kempson RL, Hendrickson MR |title=Problematic uterine smooth muscle neoplasms. A clinicopathologic study of 213 cases |journal=Am. J. Surg. Pathol. |volume=18 |issue=6 |pages=535–58 |date=June 1994 |pmid=8179071 |doi= |url=}}</ref>
* Prominent cellular [[atypia]],
* Nuclear [[atypia]], including nuclear [[pleomorphism]], hyperchromatism, irregularity in [[nuclear]] membranes, high [[nuclear]] size, and prominent [[nucleoli]].
* Abundant [[mitoses]], [[mitotic index]] higher than10 or more per 10 high-power fields.
* Areas of [[coagulative necrosis]] (Tumor cell [[necrosis]]), always accompanied by [[Cytological|cytologic]] [[atypia]] and brisk [[mitotic]] activity.
 


=== Microscopic Pathology ===
[[File:Cutaneous leiomyosarcoma - high mag.jpg|400px|thumb|left|Leimoyosarcoma H&E[https://commons.wikimedia.org/wiki/File:Cutaneous_leiomyosarcoma_-_high_mag.jpg#filehistoryhttps://commons.wikimedia.org/wiki/User:Nephron]]]<br style="clear:left" />
* On microscopic histopathological analysis leimyosarcoma can have following morphological characteristics:
* Prominent cellular atypia,
* Abundant mitoses and
* Areas of coagulative necrosis Leiomyosarcoma of somatic soft tissue has a number of histologic subtypes including epithelioid leiomyosarcoma, myxoid leiomyosarcoma, inflammatory leiomyosarcoma, granular cell leiomyosarcoma and dedifferentiated leiomyosarcoma.<sup>4</sup> The clinical importance of these subtypes has not been well studied.<ref name="pmid8179071">Bell SW, Kempson RL, Hendrickson MR (1994) [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=8179071 Problematic uterine smooth muscle neoplasms. A clinicopathologic study of 213 cases.] ''Am J Surg Pathol'' 18 (6):535-58. PMID: [https://pubmed.gov/8179071 8179071]</ref>


===Microscopic Pathology===
===Microscopic Pathology===

Latest revision as of 19:31, 8 March 2019

Leiomyosarcoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Leiomyosarcoma from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Leiomyosarcoma pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Leiomyosarcoma pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Leiomyosarcoma pathophysiology

CDC on Leiomyosarcoma pathophysiology

Leiomyosarcoma pathophysiology in the news

Blogs on Leiomyosarcoma pathophysiology

Directions to Hospitals Treating Leiomyosarcoma

Risk calculators and risk factors for Leiomyosarcoma pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [2]Associate Editor(s)-in-Chief: Nima Nasiri, M.D.[3]

Overview

Leiomyosarcoma is a rare cancerous tumor that consists of smooth muscle cells. It is an aggressive type of sarcoma, spreads through the blood stream and can affect the lungs, liver, blood vessels, or any other soft tissue in the body. The exact cause of leiomyosarcoma is not known, although genetic and environmental factors appear to be involved.It is most often found in the uterus or abdomen.


Pathophysiology

The pathogenesis of leimyosarcoma is characterized by malignant smooth muscle neoplasm that can appear in any site in the body but most commonly found in the uterus, small intestine and retro peritoneum.[1]

Gross Pathology

On gross pathology, leiomyosarcoma have the following characteristics:[2]

  • Large, solitary, poorly circumscribed masses with average size of 10 cm.
  • Fleshy colorful cut surface with areas of hemorrhage or necrosis.

Microscopic Pathology

On microscopic pathological analysis, leimyosarvoma can have following characteristic, these are include: [3]


Leimoyosarcoma H&E[1]


Microscopic Pathology

{{#ev:youtube|6OkMCMXucqw}}

References

  1. Arnold LM, Burman SD, O-Yurvati AH (2010) Diagnosis and management of primary pulmonary leiomyosarcoma. J Am Osteopath Assoc 110 (4):244-6. PMID: 20430913
  2. Wilkinson, N; Rollason, T P (2001). "Recent advances in the pathology of smooth muscle tumours of the uterus". Histopathology. 39 (4): 331–341. doi:10.1046/j.1365-2559.2001.01300.x. ISSN 0309-0167.
  3. Bell SW, Kempson RL, Hendrickson MR (June 1994). "Problematic uterine smooth muscle neoplasms. A clinicopathologic study of 213 cases". Am. J. Surg. Pathol. 18 (6): 535–58. PMID 8179071.


Template:WikiDoc Sources